Dr. John Spertus is on a mission to improve the way patients are delivered healthcare.
The Center for Pediatric Genomic Medicine at Children’s Mercy Kansas City has recently published a landmark study showing that a genome based diagnostic approach can directly impact patient care for children and infants with neurodevelopmental disorders.
Every day, medicine faces new and potentially devastating challenges. Innovative research and evidence-based medicine are keys to ensuring quality health care delivery for millions of patients around the world.
When Dr. Nicholas Franano had an idea for his first company, Proteon Therapeutics, few people thought it would be successful.
Launched in 2001, KCALSI’s development grants were specifically intended to foster scientific collaboration among regional academic institutions and generate preliminary data required for larger federal grants.
The Sprint Accelerator powered by Techstars is a three-month mentorship-driven startup accelerator. For the 2015 program ten of the most innovative healthcare startups were selected from applicants around the globe.
The Kansas City Area Life Sciences Institute (KCALSI) has embarked on a bi-state, regional strategic assessment to identify a shared vision for enhancing the life sciences over the next decade.
Sharing knowledge and creating connections that accelerate drug development, strengthen public safety, and boost economic growth based on the One Health concept—that people, animals, and the environment are all connected.
InvestMidwest is a venture capital conference that showcases 40-45 companies throughout the Midwest region in the three industry tracks of life sciences: technology and food, agriculture and bioenergy.
Quarterly updates from KCALSI’s stakeholders.
View upcoming industry events.